Kringle Pharma

4884.TPharmaceutical
Filed as Kringle Pharma, Inc. (2022-08–2026-05), Kringle Pharma, Inc (2023-05–2023-05)
In English · 14
Thu, Aug 27 · JST1 filing
13:085% STAKEKringle Pharma · Evo Fund + 1 joint holder · 6.01% → 4.79%−1.22pp
Fri, Jun 5 · JST1 filing
09:525% STAKEKringle Pharma · Evo Fund + 1 joint holder · 6.17% → 6.01%−0.16pp
Fri, May 29 · JST1 filing
12:485% STAKEKringle Pharma · Evo Fund + 1 joint holder · 7.39% → 6.17%−1.22pp
Mon, May 25 · JST1 filing
12:515% STAKEKringle Pharma · Evo Fund + 1 joint holder · 8.45% → 7.39%−1.06pp
Wed, May 20 · JST1 filing
13:485% STAKEKringle Pharma · Evo Fund + 1 joint holder · 9.02% → 8.45%−0.57pp
Thu, Apr 9 · JST1 filing
12:285% STAKEKringle Pharma · Evo Fund + 1 joint holder · 12.46% → 9.02%−3.44pp
Wed, Apr 8 · JST1 filing
11:205% STAKEKringle Pharma · Evo Fund + 1 joint holder · 15.35% → 12.46%−2.89pp
Wed, Mar 18 · JST1 filing
11:165% STAKEKringle Pharma · Evo Fund + 1 joint holder · 16.21% → 15.35%−0.86pp
Wed, Dec 3 · JST1 filing
14:185% STAKEKringle Pharma · Evo Fund + 1 joint holder · 17.23% → 16.21%−1.02pp
Thu, Oct 16 · JST1 filing
11:135% STAKEKringle Pharma · Evo Fund + 1 joint holder · 17.27% → 17.23%−0.04pp
Wed, Oct 15 · JST1 filing
10:175% STAKEKringle Pharma · Evo Fund + 1 joint holder · 18.24% → 17.27%−0.97pp
Wed, Sep 24 · JST1 filing
12:445% STAKEKringle Pharma · Evo Fund + 1 joint holder · 18.91% → 18.24%−0.67pp
Fri, Aug 22 · JST1 filing
12:345% STAKEKringle Pharma · Evo Fund + 1 joint holder · 19.60% → 18.91%−0.69pp
Fri, Aug 8 · JST1 filing
13:545% STAKEKringle Pharma · Evo Fund + 1 joint holder · 19.60%new 19.60%
All EDINET filings · 103
FiledDocumentFilerSource
2026-08-31Material event reportKringle Pharma, Inc.S100YYZP
2026-08-27Large shareholding reportRelated to S100WHGREvo FundS100YYQ6
2026-06-05Large shareholding reportRelated to S100WHGREvo FundS100Y8PH
2026-05-29Large shareholding reportRelated to S100WHGREvo FundS100Y7IU
2026-05-25Amended large shareholding reportAmends S100Y50PEvo FundS100Y64Q
2026-05-25Large shareholding reportRelated to S100WHGREvo FundS100Y61Y
2026-05-20Large shareholding reportRelated to S100WHGREvo FundS100Y50P
2026-05-11CEO/CFO certificationKringle Pharma, Inc.S100Y2OF
2026-05-11Half-year reportKringle Pharma, Inc.S100Y2Q5
2026-04-09Large shareholding reportRelated to S100WHGREvo FundS100XXR0
2026-04-08Large shareholding reportRelated to S100WHGREvo FundS100XXHS
2026-03-18Large shareholding reportRelated to S100WHGREvo FundS100XRCM
2025-12-24Material event reportKringle Pharma, Inc.S100XCY5
2025-12-19CEO/CFO certificationKringle Pharma, Inc.S100XBJ2
2025-12-19Internal control reportKringle Pharma, Inc.S100XBJ6
2025-12-19Annual reportKringle Pharma, Inc.S100XBJD
2025-12-03Large shareholding reportRelated to S100WHGREvo FundS100X7ZO
2025-10-16Large shareholding reportRelated to S100WHGREvo FundS100WVGD
2025-10-15Large shareholding reportRelated to S100WHGREvo FundS100WULJ
2025-09-24Large shareholding reportRelated to S100WHGREvo FundS100WQ7A
2025-08-22Large shareholding reportRelated to S100WHGREvo FundS100WKRA
2025-08-08Large shareholding reportEvo FundS100WHGR
2025-07-16Securities registrationKringle Pharma, Inc.S100WDC8
2025-05-12CEO/CFO certificationKringle Pharma, Inc.S100VQ6F
2025-05-12Half-year reportKringle Pharma, Inc.S100VQ66
2024-12-23Material event reportKringle Pharma, Inc.S100UZUH
2024-12-23CEO/CFO certificationKringle Pharma, Inc.S100UZU9
2024-12-23Annual reportKringle Pharma, Inc.S100UZTE
2024-12-23Internal control reportKringle Pharma, Inc.S100UZUD
2024-08-26Material event reportKringle Pharma, Inc.S100U9Q1

EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 7 financial reports not structured yet.

Not structured yet
2022-03-31quarterlyoriginal indexedS100O1XJ
2021-12-31quarterlyoriginal indexedS100NI8G
2021-09-30annualoriginal indexedS100N50Z
2021-06-30quarterlyoriginal indexedS100MA82
2021-03-31quarterlyoriginal indexedS100LCBD
2020-12-31quarterlyoriginal indexedS100KSQI
2020-09-30annualoriginal indexedS100KGH2